UroGen Pharma Correlations

URGN Stock  USD 9.46  0.17  1.83%   
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UroGen Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UroGen Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

UroGen Pharma Correlation With Market

UroGenDowDiversified AwayUroGenDowDiversified Away100%

Very weak diversification

The correlation between UroGen Pharma and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding UroGen Pharma and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UroGen Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in UroGen Stock, please use our How to Invest in UroGen Pharma guide.

Moving together with UroGen Stock

  0.61ILMN Illumina Sell-off TrendPairCorr
  0.88KURA Kura OncologyPairCorr
  0.83ABOS Acumen PharmaceuticalsPairCorr
  0.82ADTX Aditxt IncPairCorr
  0.72RYTM Rhythm PharmaceuticalsPairCorr
  0.68ANAB AnaptysBio Earnings Call Next WeekPairCorr
  0.9STRO Sutro BiopharmaPairCorr
  0.86TCRX Tscan TherapeuticsPairCorr
  0.74TERN Terns PharmaceuticalsPairCorr
  0.77CRNX Crinetics Pharmaceuticals Buyout TrendPairCorr
  0.69CTMX CytomX Therapeutics Earnings Call Next WeekPairCorr
  0.81DAWN Day One BiopharmaceuPairCorr

Moving against UroGen Stock

  0.51PFE Pfizer IncPairCorr
  0.51PHGE Biomx IncPairCorr
  0.4GANX Gain TherapeuticsPairCorr
  0.38OPT OptheaPairCorr
  0.31FENC Fennec PharmaceuticalsPairCorr
  0.31CUE Cue BiopharmaPairCorr
  0.31LTRN Lantern PharmaPairCorr
  0.51CGTX Cognition TherapeuticsPairCorr
  0.45DBVT DBV Technologies Earnings Call This WeekPairCorr
  0.73SSNLF Samsung ElectronicsPairCorr
  0.62OBI Ondine BiomedicalPairCorr
  0.44EC Ecopetrol SA ADR Sell-off TrendPairCorr
  0.4KO Coca ColaPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
IKNAELVN
IKNAINBX
ELVNINBX
SRRKTARA
ELVNCELC
IKNACELC
  
High negative correlations   
VACCSRRK
VACCTARA
VACCXLO
VACCIKNA
VACCELVN
VACCCELC

Risk-Adjusted Indicators

There is a big difference between UroGen Stock performing well and UroGen Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze UroGen Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ELYM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
INBX  2.46 (0.01) 0.00 (0.04) 0.00 
 5.54 
 16.41 
MACK  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CELC  2.63 (0.38) 0.00 (0.72) 0.00 
 5.38 
 21.63 
ELVN  2.47 (0.24) 0.00 (0.37) 0.00 
 4.35 
 19.31 
IKNA  1.73 (0.35) 0.00 (0.64) 0.00 
 3.87 
 16.13 
XLO  7.61  0.96  0.13 (0.96) 7.32 
 12.00 
 137.08 
TARA  5.77  1.19  0.23  2.78  4.44 
 12.86 
 79.13 
SRRK  3.31  0.71  0.22  0.39  2.81 
 6.72 
 31.62 
VACC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

UroGen Pharma Corporate Management

Dong KimChief OfficerProfile
Jason JDChief CounselProfile
Sari PrutchiSagivMarketing DirectorProfile
Jason SmithChief CounselProfile
Bryon WornsonAdvocacy TalentProfile
Eric ZantenDirector CommunicationsProfile
Christopher CPAChief OfficerProfile

Discover investing ideas

Utilize additional investing modules